Director · Olema Pharmaceuticals, Inc. · Olema Pharmaceuticals, Inc. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
2,911
Price
—
Executed
Apr 28, 2026
Disclosed
Apr 29, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Apr 28 executedApr 29, 2026 disclosed
OLMA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Olema Pharmaceuticals, Inc. — Stock Option (Right to Buy)
Ticker
OLMA
Shares
2,911
Price per share
$0
Execution date (reported)
Apr 28, 2026
Owned after transaction
2,911 shares
Days from execution to publication
1
What this establishes
Raman Prakash filed this Form 4 reporting a grant or award of OLMA on Apr 28, 2026. It became public on Apr 29, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Raman Prakashcik:0002018686
Issuer
Olema Pharmaceuticals, Inc.cik:0001750284
Revision history · 0
No field has changed since this record was first ingested.
